Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jinxin Fertility GroupJXFGF 81 Net-Net Working Capital is $-0.20 as of Dec. 2025. GuruFocus rates JXFGF with a GF Score™ of 81/100 and a GF Value™ of $0.51. The stock has 8 warning signs investors should review. Among 193 Healthcare Providers & Services companies, Jinxin Fertility Group ranks worse than 518134.2% on this metric.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.
Jinxin Fertility Group's Net-Net Working Capital for the quarter that ended in Dec. 2025 was $-0.20.
The industry rank for Jinxin Fertility Group's Net-Net Working Capital or its related term are showing as below:
JXFGF's Price-to-Net-Net-Working-Capital is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 7.71 * Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.
Jinxin Fertility Group (OTCPK:JXFGF) Net-Net Working Capital Explanation
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.
Jinxin Fertility Group Net-Net Working Capital Related Terms
Jinxin Fertility Group Net-Net Working Capital Historical Data
* Premium members only.
The historical data trend for Jinxin Fertility Group's Net-Net Working Capital can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinxin Fertility Group Net-Net Working Capital Chart
JXFGF vs HCA, THC, DVA: Net-Net Working Capital Comparison
For the Medical Care Facilities subindustry, Jinxin Fertility Group's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group Price-to-Net-Net-Working-Capital vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's Price-to-Net-Net-Working-Capital distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's Price-to-Net-Net-Working-Capital falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.
In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
This is a conservative way of estimating the company's value.
What does a Net-Net Working Capital of $-0.20 mean?
Jinxin Fertility Group (JXFGF) has a Net-Net Working Capital of $-0.20 as of Dec. 2025. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Jinxin Fertility Group According to the industry distribution chart, Jinxin Fertility Group ranks #999999 out of 193 companies in the Healthcare Providers & Services industry.
Is Jinxin Fertility Group's Net-Net Working Capital too high?
Jinxin Fertility Group's current Net-Net Working Capital is $-0.20. Based on the distribution chart, Jinxin Fertility Group ranks #999999 out of 193 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Jinxin Fertility Group has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's Net-Net Working Capital compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #999999 out of 193 companies for Net-Net Working Capital. This places Jinxin Fertility Group in the lower half of its industry. The industry median Net-Net Working Capital is 7.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Healthcare Providers & Services company?
The median Net-Net Working Capital among Healthcare Providers & Services companies is 7.71, based on 193 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Jinxin Fertility Group For the Healthcare Providers & Services industry, the median Net-Net Working Capital is 7.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinxin Fertility Group's current Net-Net Working Capital is $-0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Jinxin Fertility Group (JXFGF) has a current Net-Net Working Capital of $-0.20. The stock's GF Value™ is $0.51, compared to a current price of $0.29 — trading 43.1% below its estimated fair value. The current Net-Net Working Capital is $-0.20. Jinxin Fertility Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For Jinxin Fertility Group (JXFGF), the current Net-Net Working Capital is $-0.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (JXFGF) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of $0.29 is trading 43.1% below its estimated GF Value™ of $0.51.
Key valuation signals for JXFGF:
Net-Net Working Capital: $-0.20
GF Value™: $0.51 vs. price of $0.29 (43.1% below fair value)
No single metric tells the full story. See the JXFGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
81GF Score
Get the complete analysis for JXFGF
Net-Net Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JXFGF has been successfully added to your 
